Tatiana I. Spiridonova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatiana I. Spiridonova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anna Ivanovna Kozelskaya
Tomsk Polytechnic University
1 shared publication - Apollinariya A. Volokhova
B.P. Veinberg Research and Educational Center, Tomsk Polytechnic University, Tomsk, Russian Federation; Department of Translational Cellular and Molecular Biomedicine, Chemical Faculty, National Research Tomsk State University, Russian Federation
1 shared publication - Arina O. Khvastunova
Department of Translational Cellular and Molecular Biomedicine, Chemical Faculty, National Research Tomsk State University, 36 Lenin Avenue, 634050 Tomsk, Russia
1 shared publication - Dmitriy A. Fedorishin
Department of Natural Compounds, Chemical Faculty, Pharmaceutical and Medical Chemistry, National Research Tomsk State University, Tomsk 634050, Russia
1 shared publication - Irina Aleksandrovna Kurzina
Chemistry Department, National Research Tomsk State University, Arkady Ivanov St. 49, 634028 Tomsk, Russia
1 shared publication - Julia Kzhyshkowska
Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
1 shared publication
Latest Publications
- Open Access
Reactive Magnetron Plasma Modification of Electrospun PLLA Scaffolds with Incorporated Chloramphenicol for Controlled Drug Release
Surface modification with the plasma of the direct current reactive magnetron sputtering has demonstrated its efficacy as a tool for enhancing the biocompatibility of polymeric electrospun scaffolds. Improvement of the surface wettability of materials with water, as well as the formation of active chemical bonds in the near-surface layers, are the main reasons for the described effect. These surface effects are also known to increase the release rate of drugs incorporated in fibers. Herein, we investigated the effect of plasma modification on the chloramphenicol release from electrospun poly (lactic acid) fibrous scaffolds. Scaffolds with high—50 wt./wt.%—drug content were obtained. It was shown that plasma modification leads to an increase in the drug release rate and drug diffusion coefficient, while not deteriorating surface morphology and mechanical properties of scaffolds. The materials’ antibacterial activity was observed to increase in the first day of the experiment, while remaining on the same level as the unmodified group during the next six days. The proposed technique for modifying the surface of scaffolds will be useful for obtaining drug delivery systems with controlled accelerated release, which can expand the possibilities of local applications of antibiotics and other drugs.
Open AccessReactive Magnetron Plasma Modification of Electrospun PLLA Scaffolds with Incorporated Chloramphenicol for Controlled Drug Release
Surface modification with the plasma of the direct current reactive magnetron sputtering has demonstrated its efficacy as a tool for enhancing the biocompatibility of polymeric electrospun scaffolds. Improvement of the surface wettability of materials with water, as well as the formation of active chemical bonds in the near-surface layers, are the main reasons for the described effect. These surface effects are also known to increase the release rate of drugs incorporated in fibers. Herein, we investigated the effect of plasma modification on the chloramphenicol release from electrospun poly (lactic acid) fibrous scaffolds. Scaffolds with high—50 wt./wt.%—drug content were obtained. It was shown that plasma modification leads to an increase in the drug release rate and drug diffusion coefficient, while not deteriorating surface morphology and mechanical properties of scaffolds. The materials’ antibacterial activity was observed to increase in the first day of the experiment, while remaining on the same level as the unmodified group during the next six days. The proposed technique for modifying the surface of scaffolds will be useful for obtaining drug delivery systems with controlled accelerated release, which can expand the possibilities of local applications of antibiotics and other drugs.